Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Surgical Research

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JSS.2007.03.058PMID 17727886PMCID PMC2040037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

  2006cited by this paper
• Evaluation of Serum Amyloid A as a Biomarker for Gastric Cancer

  2006cited by this paper
• Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.

  2006cited by this paper
• Principles and practice of pediatric oncology

  2006cited by this paper
• Novel peptides secreted from human neuroblastoma: useful clinical tools?

  2006cited by this paper
• Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?

  2006cited by this paper
• Population Proteomics

  2006cited by this paper
• Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment

  2005cited by this paper
• Correcting common errors in identifying cancer-specific serum peptide signatures.

  2005cited by this paper
• Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins.

  2005cited by this paper
• Protein chip array profiling analysis of sera from neuroblastoma patients.

  2005cited by this paper
• alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.

  2004cited by this paper
• Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer

  2004cited by this paper
• α1‐Acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis

  2004cited by this paper
• Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer

  2004cited by this paper
• Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer

  2004cited by this paper
• Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling

  2004cited by this paper
• Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.

  2004cited by this paper
• Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in Small cell lung cancer

  2004cited by this paper
• -Macroglobulin: A Novel Cytochemical Marker Characterizing Preneoplastic and Neoplastic Rat Liver Lesions Negative for Hitherto Established Cytochemical Markers

  2004cited by this paper
• The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues

  2003cited by this paper
• Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection

  2002cited by this paper
• Proteomic Detection of Changes in Protein Synthesis Induced by NGX6 Transfected in Human Nasopharyngeal Carcinoma Cells

  2001cited by this paper
• Significance of serum amyloid a on the prognosis in patients with renal cell carcinoma

  2001cited by this paper
• Suppression of primary tumor growth in a mouse model of human neuroblastoma.

  2000influential reference
• Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma.

  1999cited by this paper
• Carbohydrate composition and immunomodulatory activity of different glycoforms of α1-acid glycoprotein

  1997cited by this paper
• IL-6 and APPs: anti-inflammatory and immunosuppressive mediators.

  1997cited by this paper
• Neoplastic diseases of childhood

  1997cited by this paper
• Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer.

  1995cited by this paper
• [The change of serum alpha 1-antitrypsin level in patients with spontaneous pneumothorax].

  1995cited by this paper
• Principles and Practice of Pediatric Oncology

  1989cited by this paper
• Plasma protein synthesis in experimental cancer compared to paraneoplastic conditions, including monokine administration.

  1987cited by this paper
• Serum alpha-1 proteinase inhibitor in advanced cancer: mass variants and functionally inert forms.

  1987cited by this paper
• Serum α-1 Proteinase Inhibitor in Advanced Cancer: Mass Variants and Functionally Inert Forms

  1987cited by this paper
• Serum Amyloid P‐Component Levels in Patients with Malignancy

  1986cited by this paper
• Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis.

  1986cited by this paper
• Alpha 1-antitrypsin and cancer of the pancreas.

  1985cited by this paper
• α1-Antitrypsin and Cancer of the Pancreas

  1985cited by this paper
• Immunosuppressive plasma factors in malignant disease.

  1985cited by this paper
• Serum amyloid A to monitor cancer dissemination.

  1979cited by this paper
• Increase of the alpha1-antitrypsin in lung cancers.

  1976cited by this paper

• GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma

  2018influential citation
• The role of proteomics in colorectal cancer biomarker discovery

  2015cites this paper
• Alterations in Small Cell Lung Cancer

  2013cites this paper
• Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer

  2013cites this paper
• The impact of pre-analytical conditions on the serum proteome: heat-stabilization versus nitrogen storage

  2013cites this paper
• Neglected markers: Altered serum proteome in murine models of disease

  2012cites this paper
• Preliminary proteomic analysis of human serum from patients with laryngeal carcinoma

  2012cites this paper
• Application of Proteomics to Soft Tissue Sarcomas

  2012cites this paper
• 1 Acute Phase Proteins as Cancer Biomarkers

  2012cites this paper
• Acute Phase Proteins as Cancer Biomarkers

  2011cites this paper
• An integrated proteomic approach to identifying circulating biomarkers in high‐risk neuroblastoma and their potential in relapse monitoring

  2011cites this paper
• Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models.

  2010cites this paper
• High‐abundance protein depletion: Comparison of methods for human plasma biomarker discovery

  2010cites this paper
• Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model

  2010cites this paper
• Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin

  2010cites this paper
• Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.

  2010cites this paper
• Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress

  2010cites this paper
• Proteomic analysis of biomarkers associated with immunotherapy in murine tumour models

  2009cites this paper
• A qualitative proteome investigation of the sediment portion of human urine: Implications in the biomarker discovery process

  2009cites this paper
• Proteomic approaches in neuroblastoma: a complementary clinical platform for the future

  2009cites this paper
• Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.

  2009cites this paper
• Oxidative status in neuroblastoma: a source of stress?

  2008cites this paper
• Serum amyloid A: An acute-phase protein involved in tumour pathogenesis

  2008cites this paper
• The Optimized Conditions of Two Dimensional Polyacrylamide Gel Electrophoresis for Serum Proteomics

  2008cites this paper